Oxygenta Pharmaceutical Ltd
OXYGENTAPHOxygenta Pharmaceutical Ltd
OXYGENTAPH
Price Chart
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -1,125.84 | -15.66 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 12.14 | 0.59 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
0
Peers
Compare with peersSunshine Capital Ltd
Vashu Bhagnani Industries Ltd
Worth Investment & Trading Co Ltd
Aayush Wellness Ltd
Visco Trade Associates Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12.43 | 8.77 | 14.23 | 20.82 | 17.74 | 54.31 | 61.88 | 31.13 | 39.74 | 45.71 | ||||||||||
Raw Materials | 8.31 | 5.96 | 9.51 | 17.75 | 14.99 | 43.02 | 42.67 | 28.64 | 35.06 | 53.32 | ||||||||||
| Power & Fuel Cost | 1.21 | 1.08 | 1.12 | 0.89 | 1.00 | 2.79 | 3.04 | 4.16 | 4.15 | |||||||||||
| Employee Cost | 3.07 | 2.86 | 2.90 | 2.71 | 2.50 | 4.08 | 0.58 | 5.74 | 5.87 | |||||||||||
| Selling & Administrative Expenses | 1.37 | 1.70 | 1.00 | 1.43 | 1.17 | 1.79 | 1.88 | 1.75 | 2.48 | |||||||||||
| Operating & Other expenses | 2.63 | 1.40 | 2.34 | -0.23 | 1.92 | -3.50 | 11.69 | -1.33 | 1.80 | |||||||||||
EBITDA | -4.16 | -4.23 | -2.64 | -1.73 | -3.84 | 6.13 | 2.02 | -7.83 | -9.62 | -7.61 | ||||||||||
| Depreciation/Amortization | 0.82 | 0.90 | 0.94 | 1.02 | 1.00 | 1.20 | 1.59 | 2.05 | 2.66 | 2.81 | ||||||||||
| PBIT | -4.98 | -5.13 | -3.58 | -2.75 | -4.84 | 4.93 | 0.43 | -9.88 | -12.28 | -10.42 | ||||||||||
| Interest & Other Items | 0.51 | 0.60 | 0.90 | 0.75 | 1.09 | 1.78 | 0.92 | 1.49 | 1.59 | 1.70 | ||||||||||
| PBT | -5.49 | -5.73 | -4.48 | -3.50 | -5.93 | 3.15 | -0.49 | -11.37 | -13.87 | -12.12 | ||||||||||
| Taxes & Other Items | 0.00 | 0.09 | 0.05 | -0.24 | -0.15 | 0.21 | 0.12 | 0.20 | -10.39 | -11.84 | ||||||||||
| Net Income | -5.49 | -5.82 | -4.53 | -3.26 | -5.78 | 2.94 | -0.61 | -11.57 | -3.48 | -0.28 | ||||||||||
| EPS | -5.38 | -5.71 | -4.44 | -3.20 | -5.67 | 2.88 | -0.50 | -8.15 | -1.46 | -0.08 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
-0
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Oxygenta Pharmaceutical Ltd | -90.58 | -15.66 | — |
| Sunshine Capital Ltd | -22.26 | 18.98 | — |
| Vashu Bhagnani Industries Ltd | 115.65 | 11.92 | — |
| Worth Investment & Trading Co Ltd | 332.72 | 17.90 | — |
Price Comparison
Compare OXYGENTAPH with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 23.56%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
OXYGENTAPH has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeOxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as against net loss of Rs 4.56 crore during the previous quarter ended June 2023. Sales rose 83.97% to Rs 12.62 crore in the quarter ended June 2024 as against Rs 6.86 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.626.86 84 OPM %-14.03-53.06 - PBDT-2.16-3.93 45 PBT-2.81-4.43 37 NP-1.36-4.56 70 Powered by Capital Market - Live
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 13.8%, vs industry avg of -7.97%
Increasing Market Share
Over the last 5 years, market share increased from 0.37% to 1.19%